Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Kolon TissueGene shrinks workforce after pivotal osteoarthritis trial miss

Kolon TissueGene shrinks workforce after pivotal osteoarthritis trial miss

August 18, 2026Posted inBiotechnology

Following a phase 3 knee osteoarthritis failure that its CEO acknowledged caused “great disappointment and concern,” Kolon TissueGene is laying off 37 employees at its Maryland headquarters.

Post navigation

Previous Post
Exercise-Boosting Molecule May Help Improve Muscle Health in Type 2 Diabetes
Next Post
TUM develops single-photon sources to advance quantum communication tum-develops-single-photon-sources-to-advance-quantum-communication

Recent Posts

  • Multi-lineage reprogramming and NOTCH-associated signaling remodeling characterize the aggressive biology of early-onset colorectal cancer
  • SYNGAP1 burden study will survey at least 125 U.S. caregivers
  • Research report: Simplifying the calibration of current measurement instruments with diamond quantum sensing technology
  • Cross-sectional study links multimorbidity, resilience, sleep and depressive symptoms in older adults
  • Machine learning reveals buckling prediction limits in cold-formed steel columns

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top